The VPAC 2 agonist peptide histidine isoleucine (PHI) up‐regulates glutamate transport in the corpus callosum of a rat model of amyotrophic lateral sclerosis (hSOD1 G93A ) by inhibiting caspase‐3 mediated inactivation of GLT‐1a
Open Access
- 5 July 2011
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 25 (10) , 3674-3686
Abstract
Degeneration of corpus callosum appears in patients with amyotrophic lateral sclerosis (ALS) before clinical signs of upper motor neuron death. Considering the ALS‐associated impairment of astrocytic glutamate uptake, we have characterized the expression and activity of the glutamate transporter isoforms GLT‐1a and GLT‐1b in the corpus callosum of transgenic rats expressing a mutated form of the human superoxide dismutase 1 (hSOD1 G93A ). We have also studied the effect of peptide histidine isoleucine (PHI), a vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase‐activating polypeptide (PACAP) receptor 2 (VPAC 2 ) agonist on glutamate transporters both in vivo and in callosal astrocytes. Before the onset of motor symptoms, the expression of both transporter isoforms was correlated with a constitutive activity of caspase‐3. This enzyme participates in the down‐regulation of GLT‐1 in ALS, and here we demonstrated its involvement in the selective degradation of GLT‐1a in the white matter. A single stereotactic injection of PHI into the corpus callosum of symptomatic rats decreased caspase‐3 activity and promoted GLT‐1a expression and uptake activity. Together, with evidence for a reduced expression of prepro‐VIP/PHI mRNA in the corpus callosum of transgenic animals, these data shed light on the modulatory role of the VIP/PHI system on the glutamatergic transmission in ALS.—Goursaud, S., Focant, M. C., Berger, J. V., Nizet, Y., Maloteaux, J.‐M., Hermans, E. The VPAC 2 agonist peptide histidine isoleucine (PHI) up‐regulates glutamate transport in the corpus callosum of a rat model of amyotrophic lateral sclerosis (hSOD1 G93A ) by inhibiting caspase‐3 mediated inactivation of GLT‐1a. FASEB J. 25, 3674–3686 (2011). www.fasebj.orgKeywords
This publication has 58 references indexed in Scilit:
- Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosisNeurology, 2010
- Cultured astrocytes derived from corpus callosum or cortical grey matter show distinct glutamate handling propertiesJournal of Neurochemistry, 2009
- Biomarkers in amyotrophic lateral sclerosisThe Lancet Neurology, 2009
- Correlation between pyramidal tract degeneration and widespread white matter involvement in amyotrophic lateral sclerosis: A study with tractography and diffusion-tensor imagingAmyotrophic Lateral Sclerosis, 2009
- Callosal dysfunction in amyotrophic lateral sclerosis correlates with diffusion tensor imaging of the central motor systemNeuromuscular Disorders, 2008
- Transcallosal inhibition in amyotrophic lateral sclerosisClinical Neurophysiology, 2007
- Mechanisms of Disease: astrocytes in neurodegenerative diseaseNature Clinical Practice Neurology, 2006
- Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosisBrain, 2004
- Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1992
- Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosisAnnals of Neurology, 1990